SA515370253B1 - مركب أميد عطري غير متجانس الحلقة يحتوي على نتروجين ثنائي الحلقة - Google Patents
مركب أميد عطري غير متجانس الحلقة يحتوي على نتروجين ثنائي الحلقةInfo
- Publication number
- SA515370253B1 SA515370253B1 SA515370253A SA515370253A SA515370253B1 SA 515370253 B1 SA515370253 B1 SA 515370253B1 SA 515370253 A SA515370253 A SA 515370253A SA 515370253 A SA515370253 A SA 515370253A SA 515370253 B1 SA515370253 B1 SA 515370253B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- aromatic heterocyclic
- breast cancer
- containing aromatic
- heterocyclic amide
- bicyclic nitrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013122180 | 2013-06-10 | ||
PCT/JP2014/065181 WO2014199933A1 (ja) | 2013-06-10 | 2014-06-09 | 二環式含窒素芳香族ヘテロ環アミド化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
SA515370253B1 true SA515370253B1 (ar) | 2017-03-06 |
Family
ID=52022229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SA515370253A SA515370253B1 (ar) | 2013-06-10 | 2015-12-09 | مركب أميد عطري غير متجانس الحلقة يحتوي على نتروجين ثنائي الحلقة |
Country Status (21)
Country | Link |
---|---|
US (1) | US9428501B2 (ru) |
EP (1) | EP3009424B1 (ru) |
JP (1) | JP5924453B2 (ru) |
KR (1) | KR20160018686A (ru) |
CN (1) | CN105308024B (ru) |
AR (1) | AR096552A1 (ru) |
AU (1) | AU2014279240A1 (ru) |
BR (1) | BR112015030248A2 (ru) |
CA (1) | CA2914982A1 (ru) |
EA (1) | EA028545B1 (ru) |
ES (1) | ES2661259T3 (ru) |
HK (1) | HK1220446A1 (ru) |
IL (1) | IL242997A (ru) |
MX (1) | MX2015016965A (ru) |
PH (1) | PH12015502744A1 (ru) |
PL (1) | PL3009424T3 (ru) |
PT (1) | PT3009424T (ru) |
SA (1) | SA515370253B1 (ru) |
SG (1) | SG11201510125WA (ru) |
TW (1) | TW201536771A (ru) |
WO (1) | WO2014199933A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015338042A1 (en) | 2014-10-28 | 2017-04-27 | Shionogi & Co., Ltd. | Heterocyclic derivative having AMPK activating effect |
MA41158A (fr) * | 2014-12-09 | 2017-10-17 | Astellas Pharma Inc | Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif |
WO2016093255A1 (ja) * | 2014-12-09 | 2016-06-16 | アステラス製薬株式会社 | 二環式含窒素芳香族ヘテロ環アミド化合物を有効成分とする医薬組成物 |
MA41157A (fr) * | 2014-12-09 | 2017-10-17 | Astellas Pharma Inc | Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif |
WO2017196936A1 (en) * | 2016-05-12 | 2017-11-16 | Regents Of The University Of Minnesota | Indole and indazole cyanocinnamate compounds and therapeutic uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19932314A1 (de) * | 1999-07-10 | 2001-01-11 | Merck Patent Gmbh | Benzofuranderivate |
AU2001288899A1 (en) * | 2000-09-06 | 2002-03-22 | The Scripps Research Institute | Inhibitors of nadh:ubiquinone oxidoreductase |
NZ570524A (en) * | 2006-03-28 | 2011-08-26 | High Point Pharmaceuticals Llc | Benzothiazoles having histamine H3 receptor activity |
US7432255B2 (en) * | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
BRPI0819517B1 (pt) * | 2007-12-21 | 2018-03-20 | 3M Innovative Properties Company | Método para detectar um micro-organismo produtor de gás |
AU2008339572B2 (en) * | 2007-12-21 | 2012-05-10 | Astrazeneca Ab | Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
CN102099357B (zh) * | 2008-04-23 | 2014-07-02 | 里格尔药品股份有限公司 | 用于治疗代谢障碍的甲酰胺化合物 |
EA025611B1 (ru) | 2010-07-29 | 2017-01-30 | Райджел Фармасьютикалз, Инк. | Активирующие ampk гетероциклические соединения и способы их использования |
WO2013116491A1 (en) | 2012-02-01 | 2013-08-08 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds and methods for using them |
-
2014
- 2014-06-09 US US14/418,672 patent/US9428501B2/en active Active
- 2014-06-09 WO PCT/JP2014/065181 patent/WO2014199933A1/ja active Application Filing
- 2014-06-09 TW TW103119885A patent/TW201536771A/zh unknown
- 2014-06-09 CA CA2914982A patent/CA2914982A1/en not_active Abandoned
- 2014-06-09 AU AU2014279240A patent/AU2014279240A1/en not_active Abandoned
- 2014-06-09 EP EP14810281.7A patent/EP3009424B1/en active Active
- 2014-06-09 KR KR1020167000279A patent/KR20160018686A/ko not_active Application Discontinuation
- 2014-06-09 JP JP2015522759A patent/JP5924453B2/ja not_active Expired - Fee Related
- 2014-06-09 AR ARP140102215A patent/AR096552A1/es unknown
- 2014-06-09 MX MX2015016965A patent/MX2015016965A/es active IP Right Grant
- 2014-06-09 BR BR112015030248A patent/BR112015030248A2/pt active Search and Examination
- 2014-06-09 ES ES14810281.7T patent/ES2661259T3/es active Active
- 2014-06-09 PL PL14810281T patent/PL3009424T3/pl unknown
- 2014-06-09 PT PT148102817T patent/PT3009424T/pt unknown
- 2014-06-09 CN CN201480033143.0A patent/CN105308024B/zh not_active Expired - Fee Related
- 2014-06-09 EA EA201592301A patent/EA028545B1/ru not_active IP Right Cessation
- 2014-06-09 SG SG11201510125WA patent/SG11201510125WA/en unknown
-
2015
- 2015-12-09 PH PH12015502744A patent/PH12015502744A1/en unknown
- 2015-12-09 IL IL242997A patent/IL242997A/en not_active IP Right Cessation
- 2015-12-09 SA SA515370253A patent/SA515370253B1/ar unknown
-
2016
- 2016-07-15 HK HK16108380.3A patent/HK1220446A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MX2015016965A (es) | 2016-04-25 |
US9428501B2 (en) | 2016-08-30 |
JPWO2014199933A1 (ja) | 2017-02-23 |
IL242997A (en) | 2017-04-30 |
PH12015502744A1 (en) | 2016-03-21 |
PT3009424T (pt) | 2018-01-16 |
CN105308024B (zh) | 2017-10-27 |
JP5924453B2 (ja) | 2016-05-25 |
WO2014199933A1 (ja) | 2014-12-18 |
PL3009424T3 (pl) | 2018-03-30 |
EA201592301A1 (ru) | 2016-05-31 |
US20150266869A1 (en) | 2015-09-24 |
BR112015030248A2 (pt) | 2017-07-25 |
SG11201510125WA (en) | 2016-01-28 |
EP3009424B1 (en) | 2017-12-20 |
EP3009424A1 (en) | 2016-04-20 |
CA2914982A1 (en) | 2014-12-18 |
AU2014279240A1 (en) | 2016-01-07 |
KR20160018686A (ko) | 2016-02-17 |
TW201536771A (zh) | 2015-10-01 |
EA028545B1 (ru) | 2017-11-30 |
AR096552A1 (es) | 2016-01-13 |
EP3009424A4 (en) | 2016-11-30 |
ES2661259T3 (es) | 2018-03-28 |
HK1220446A1 (zh) | 2017-05-05 |
CN105308024A (zh) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015001985A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim. | |
MX2018012174A (es) | Degradantes de proteina homologa de proteina murina de cromosoma diminuto doble (mdm2). | |
MX2019010709A (es) | Heterociclos biciclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr). | |
MY170904A (en) | Ret inhibitor | |
MA40076A (fr) | Inhibiteurs de syk | |
PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
MX2015014234A (es) | Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1. | |
CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
SA515370253B1 (ar) | مركب أميد عطري غير متجانس الحلقة يحتوي على نتروجين ثنائي الحلقة | |
MX2018015657A (es) | Compuestos heterociclico como antibacterianos. | |
MX359664B (es) | Tratamiento de cáncer de mama. | |
MX2014011583A (es) | Metodos y composiciones para el tratamiento de la familia de tumores del sarcoma de ewing. | |
MX2014012477A (es) | Inhibidores pirrolopirazona de tanquirasa. | |
PH12016502291A1 (en) | Indolizine derivatives as phosphoinositide 3-kinases inhibitors | |
MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
PH12014501829A1 (en) | Bicyclic pyrazinone derivatives | |
EA034822B9 (ru) | Производные n-пиридинилацетамида в качестве ингибиторов сигнального пути wnt | |
MX359656B (es) | Derivados de oxoquinazolinil-butanamida. | |
PH12015501038A1 (en) | Inhibitors of iap | |
NZ713187A (en) | Anti-angiogenesis compound, intermediate and use thereof | |
MX2015009818A (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple. | |
MX2017006026A (es) | Apilimod para uso en el tratamiento de cancer colorrectal. | |
MX2016008042A (es) | Derivados de imidazopirazinona. | |
SG10201900954SA (en) | Heterocycles as Modulators of Kinase Activity | |
MX2018001575A (es) | Compuestos triciclicos y su uso en el tratamiento del cancer. |